British Journal of Dermatology · 1992 · 75 citations · 19 references
MedicineDermatologyPharmacotherapyAntimicrobial PharmacologyAntimicrobial PharmacotherapyDermatopathologyAntibiotic ProphylaxisAntibiotic ResistanceSkin InfectionsErysipelas Skin LesionsPenicillin ResistanceSkin Infection Treatment
A prospective, randomized, multicentre trial was conducted to evaluate the efficacy and safety of roxithromycin (150 mg b.i.d. orally) and penicillin (2.5 MU x 8 daily intravenously, then 6 MU daily orally) in the treatment of hospitalized adult patients with erysipelas. Seventy-two patients entered the study. Thirty-one patients in the roxithromycin group and 38 patients in the penicillin group completed the trial. The overall efficacy rates (cure without additional antibiotics) were 84% (26/31) in the roxithromycin group and 76% (29/38) in the penicillin group (P = 0.43). No side-effects were observed in the roxithromycin-treated patients whereas rashes occurred in two cases in the penicillin group, leading to exclusion from the study. Oral roxithromycin can thus be considered an effective and well-tolerated treatment for erysipelas in adult hospitalized patients.
19
Principles and Practice of Infectious Diseases.
Annals of Internal Medicine · 1985 · 1.6K citations
Microbiologic Evaluation of Cutaneous Cellulitis in Adults
Edward W. Hook · Archives of Internal Medicine · 1986 · 237 citations
Streptococcal Cause of Erysipelas and Cellulitis in Adults
Philippe Bernard · Archives of Dermatology · 1989 · 136 citations
TR Rodgers · Journal of Clinical Pathology · 1981 · 128 citations · Full text